FDA Inspection 1166776 — LGM Pharma LLC
The FDA completed an inspection of LGM Pharma LLC on Apr 8, 2022 in Erlanger, KY. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 8, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Erlanger, KY (United States)